BAY 2666605
BAY 2666605 is a potent, orally bioavailable dual inhibitor of PDE3A (IC50=87 nM) and PDE3B (IC50=50 nM) . This research compound exhibits anticancer activity and is utilized in preclinical studies to investigate PDE3 signaling in cellular proliferation and tumor models.
Product Specifications
CAS Number
2275774-60-0
Product Name Alternative
Phosphodiesterase (PDE), Inhibitor, inhibit, PDE3A, PDE3A-SLFN12 Complex, PDE3B, orally active, BAY2666605, BAY-2666605, BAY 2666605, anticancer effect
Field of Research
Metabolism Research
Purity
99.81% (May vary between batches)
Solubility
DMSO:245 mg/mL (695.47 mM)
Smiles
C[C@@H]1OC (=O) NN=C1c1ccc (-c2ccc (F) cc2) c (c1) C (F) (F) F
Molecular Formula
C17H12F4N2O2
Molecular Weight
352.28
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2123640-01 0.01 mg
Recombinant Tyrosyl tRNA Synthetase 2, Mitochondrial (YARS2)
Sign In for Pricing
View Details MBS2123640-02 0.05 mg
Recombinant Tyrosyl tRNA Synthetase 2, Mitochondrial (YARS2)
Sign In for Pricing
View Details MBS2123640-03 0.1 mg
Recombinant Tyrosyl tRNA Synthetase 2, Mitochondrial (YARS2)
Sign In for Pricing
View Details MBS2123640-04 0.2 mg
Recombinant Tyrosyl tRNA Synthetase 2, Mitochondrial (YARS2)
Sign In for Pricing
View Details